The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
Morgan Stanley (NYSE:MS) initiated coverage on shares of Philip Morris International Inc. (NYSE:NYSE:PM) shares, bestowing an Overweight rating and establishing a price target of $140. The move ...
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
Philip Morris International Inc. (NYSE:PM) announced on Thursday that it completed the previously announced sale of its subsidiary Vectura Group Ltd. to Molex Asia Holdings Ltd. The deal terms ...
Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...
Philip Morris to pay $1.2 mln to settle probe into ... nicotine pouches The sale of single-use vapes will be banned in England from June next year, the British government said on Thursday, seeking ...
First Hawaiian Bank decreased its position in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by 4.8% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback